Candel Therapeutics (CADL) EPS (Diluted) (2021 - 2025)

Candel Therapeutics (CADL) EPS (Diluted) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Candel Therapeutics 643.41 Mn 643.41 Mn - -0.29

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.29
Sep 30, 2025 -0.43
Jun 30, 2025 -0.42
Mar 31, 2025 -0.38
Dec 31, 2024 -0.27
Sep 30, 2024 -0.90
Jun 30, 2024 -0.86
Mar 31, 2024 -0.28
Dec 31, 2023 -0.35
Sep 30, 2023 -0.33
Jun 30, 2023 -0.68
Mar 31, 2023 -0.35
Dec 31, 2022 -0.31
Sep 30, 2022 -0.31
Jun 30, 2022 -0.32
Mar 31, 2022 -1.33
Dec 31, 2021 -1.38
Sep 30, 2021 -0.34
Jun 30, 2021 -0.45